RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000084.xml
Synthesis 2020; 52(06): 901-908
DOI: 10.1055/s-0037-1610742
DOI: 10.1055/s-0037-1610742
paper
Synthesis of 2-Imidazolines via Palladium-Catalyzed Cyclization Reaction of 2,3-Allenyl Amines and Aryl Iodides
This work was financially supported by the National Natural Science Foundation of China (Grant No. 81903469), the Natural Science Foundation of Shandong Province (ZR2019BB016), and Weifang Science and Technology Development Plan Project (2019GX029).Weitere Informationen
Publikationsverlauf
Received: 30. September 2019
Accepted after revision: 17. Dezember 2019
Publikationsdatum:
09. Januar 2020 (online)
Abstract
An effective method for the synthesis of polysubstituted 2-imidazoline derivatives via palladium-catalyzed cyclization of 2,3-allenyl amines with aryl iodides is described. This pure domino process allows the formation of new carbon–carbon and carbon–nitrogen bonds in a single synthetic operation.
Supporting Information
- Supporting information for this article is available online at https://doi.org/10.1055/s-0037-1610742.
- Supporting Information
-
References
- 1 Bela S. Pharmacol. Ther. 2002; 93: 1
- 2 Le Bihan G, Rondu F, Pelé-Tounian A, Wang X, Lidy S, Touboul E, Lamouri A, Dive G, Huet J, Pfeiffer B, Renard P, Guardiola-Lemaître B, Manéchez D, Pénicaud L, Ktorza A, Godfroid J.-J. J. Med. Chem. 1999; 42: 1587
- 3 Vizi ES. Med. Res. Rev. 1986; 6: 431
- 4 Li H.-Y, Drummond S, DeLucca I, Boswell GA. Tetrahedron 1996; 52: 11153
- 5 Makoto U, Kazunori I, Takahisa S, Isao T, Masakazu T. Int. J. Immunopharmacol. 1995; 17: 597
- 6 Merriman GH, Ma L, Shum P, McGarry D, Volz F, Sabol JS, Gross A, Zhao Z, Rampe D, Wang L, Wirtz-Brugger F, Harris BA, Macdonald D. Bioorg. Med. Chem. Lett. 2005; 15: 435
- 7 Gust R, Keilitz R, Schmidt K. J. Med. Chem. 2001; 44: 1963
- 8 Azevedo LM, Lansdell TA, Ludwig JR, Mosey RA, Woloch DK, Cogan DP, Patten GP, Kuszpit MR, Fisk JS, Tepe JJ. J. Med. Chem. 2013; 56: 5974
- 9 Patel S, Player MR. Expert Opin. Invest. Drugs 2008; 17: 1865
- 10 Chen H, Sanjaya S, Wang YF, Chiba SS. Org. Lett. 2013; 15: 212
- 11 Chen H, Chiba S. Org. Biomol. Chem. 2014; 12: 42
- 12 Huang S, Shao Y, Zhang LX, Zhou XG. Angew. Chem. Int. Ed. 2015; 54 (48) 14452
- 13a Dömling A. Curr. Opin. Chem. Biol. 2002; 6: 306
- 13b Orru RV. A, de Greef M. Synthesis 2003; 1471
- 13c Zimmer R, Dinesh CU, Nandanan E, Khan FA. Chem. Rev. 2000; 100: 3067
- 13d Hashmi AS. K. Angew. Chem. Int. Ed. 2000; 39: 3590 ; Angew. Chem. 2000, 112, 3737
- 14a Huang X, Ma S. Acc. Chem. Res. 2019; 52: 1301
- 14b Mascarenas JL, Varela I, Lopez F. Acc. Chem. Res. 2019; 52: 465
- 14c Yang B, Qiu Y, Baeckvall J.-E. Acc. Chem. Res. 2018; 51: 1520
- 14d Ma S. Top. Organomet. Chem. 2005; 183
- 14e Ma S. Acc. Chem. Res. 2003; 36: 701
- 14f Yamamoto Y, Radhak-rishnan U. Chem. Soc. Rev. 1999; 28: 199
- 15 Hu J, Kong B, Liu Y, Xu XB, Zhao Y, Gong P. ChemCatChem 2017; 9: 403
- 16a Ye J, Ma S. Acc. Chem. Res. 2014; 47: 989
- 16b Jiang XP, Fu C, Ma S. Chem. Eur. J. 2008; 14: 9656
- 16c Ma S, Jiao N, Zheng Y. J. Org. Chem. 2004; 69: 5720
- 16d Ma S, Jiao N. Angew. Chem. Int. Ed. 2002; 41: 4737
- 16e Ma S, Gao W. Org. Lett. 2002; 4: 2989
- 16f Dieter PK, Yu H. Org. Lett. 2001; 3: 3855
- 16g Ha Y.-H, Kang S.-K. Org. Lett. 2002; 4: 1143
- 16h Kang S.-K, Ha Y.-H, Ko B.-S, Lim Y, Jung J. Angew. Chem. Int. Ed. 2002; 41: 343 ; Angew. Chem. 2002, 114, 353
- 16i Ma S, Jiao N. Angew. Chem. Int. Ed. 2002; 41: 4737
- 16j Ma S, Shi Z. Chem. Commun. 2002; 540
- 16k Ma S, Gao W. Synlett 2002; 65
- 16l Ma S, Duan D, Wang Y. J. Comb. Chem. 2002; 4: 239
- 16m Shimizu I, Tsuji J. Chem. Lett. 1984; 233
- 16n Ahmar M, Cazes B, Gore J. Tetrahedron Lett. 1984; 25: 4505
For reviews, see:
For recent reviews, see: